Jpmorgan Chase & CO Biocept Inc Transaction History

Jpmorgan Chase & CO

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 11, 2022	SELL	$0.88 - $2.27 $71,602 - $184,703	-81,367 Closed	0 $0
Q1 2022 May 11, 2022	SELL	$1.83 - $3.97 $4,406 - $9,559	-2,408 Reduced 2.87%	81,367 $189,000
Q4 2021 Feb 10, 2022	BUY	$3.43 - $4.22 $233,877 - $287,744	68,186 Added 437.4%	83,775 $303,000
Q3 2021 Nov 12, 2021	BUY	$3.39 - $4.34 $52,846 - $67,656	15,589 New	15,589 $63,000

Ticker BIOC
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 16,922,900
Market Cap $1.18M
Description
Biocept, Inc., a molecular oncology diagnostics company, develops and commercializes proprietary circulating tumor cell and circulating cell-free tumor DNA and RNA assays utilizing a standard blood sample. Its cancer assays provide information to healthcare providers to identify oncogenic alterations that qualify a subset of cancer patients for ...

Get notified when there are updates to the investment portfolio of Jpmorgan Chase & CO, based on Form 13F filings with the SEC.

Stay updated on Jpmorgan Chase & CO with notifications on news.